These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26813250)

  • 21. Loss of a Class A Penicillin-Binding Protein Alters β-Lactam Susceptibilities in Mycobacterium tuberculosis.
    Wivagg CN; Wellington S; Gomez JE; Hung DT
    ACS Infect Dis; 2016 Feb; 2(2):104-10. PubMed ID: 27624961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage Display Technique: A Novel Medicinal Approach to Overcome An tibiotic Resistance by Using Peptide-Based Inhibitors Against β-Lactamases.
    Muteeb G; Rehman MT; Ali SZ; Al-Shahrani AM; Kamal MA; Ashraf GM
    Curr Drug Metab; 2017; 18(2):90-95. PubMed ID: 27465983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-lactam resistance in anaerobic bacteria: a review.
    Hedberg M; Nord CE
    J Chemother; 1996 Feb; 8(1):3-16. PubMed ID: 8835102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
    Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of two-component regulatory system in β-lactam antibiotics resistance.
    Lingzhi L; Haojie G; Dan G; Hongmei M; Yang L; Mengdie J; Chengkun Z; Xiaohui Z
    Microbiol Res; 2018 Oct; 215():126-129. PubMed ID: 30172298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
    Therrien C; Levesque RC
    FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.
    Tomoshige S; Dik DA; Akabane-Nakata M; Madukoma CS; Fisher JF; Shrout JD; Mobashery S
    ACS Infect Dis; 2018 Jun; 4(6):860-867. PubMed ID: 29716193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases.
    Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J
    Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Review on Subclass B1 Metallo-β-lactamases Inhibitors: Sword for Antimicrobial Resistance.
    Kaushik A; Kaushik M; Lather V; Dua JS
    Curr Drug Targets; 2019; 20(7):756-762. PubMed ID: 30556502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
    Zhang J; Wang S; Wei Q; Guo Q; Bai Y; Yang S; Song F; Zhang L; Lei X
    Bioorg Med Chem; 2017 Oct; 25(19):5133-5141. PubMed ID: 28784300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTA: a potent metallo-β-lactamase inhibitor.
    Somboro AM; Tiwari D; Bester LA; Parboosing R; Chonco L; Kruger HG; Arvidsson PI; Govender T; Naicker T; Essack SY
    J Antimicrob Chemother; 2015 May; 70(5):1594-6. PubMed ID: 25567963
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of a beta-lactamase inhibitor peptide on bacterial membrane structure and integrity: a comparative study.
    Alaybeyoglu B; Uluocak BG; Akbulut BS; Ozkirimli E
    J Pept Sci; 2017 May; 23(5):374-383. PubMed ID: 28299853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorogenic Probes/Inhibitors of β-Lactamase and their Applications in Drug-Resistant Bacteria.
    Ding Y; Li Z; Xu C; Qin W; Wu Q; Wang X; Cheng X; Li L; Huang W
    Angew Chem Int Ed Engl; 2021 Jan; 60(1):24-40. PubMed ID: 32592283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting the metallo-β-lactamases: challenges and strategies to overcome bacterial β-lactam resistance.
    Jeffs MA; Lohans CT
    Future Med Chem; 2022 Jul; 14(14):1021-1025. PubMed ID: 35671036
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
    Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of beta-lactamase structure and function.
    Majiduddin FK; Materon IC; Palzkill TG
    Int J Med Microbiol; 2002 Jul; 292(2):127-37. PubMed ID: 12195735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solving staphylococcal resistance to beta-lactams.
    Chambers HF
    Trends Microbiol; 2003 Apr; 11(4):145-8. PubMed ID: 12706985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.
    Hecker SJ; Reddy KR; Totrov M; Hirst GC; Lomovskaya O; Griffith DC; King P; Tsivkovski R; Sun D; Sabet M; Tarazi Z; Clifton MC; Atkins K; Raymond A; Potts KT; Abendroth J; Boyer SH; Loutit JS; Morgan EE; Durso S; Dudley MN
    J Med Chem; 2015 May; 58(9):3682-92. PubMed ID: 25782055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.